Ranger Micro Cap Fund Institutional Class RFIMX

Medalist Rating as of | See Ranger Funds Investment Hub
  • NAV / 1-Day Return 8.72  /  −0.91 %
  • Total Assets 12.2M
  • Adj. Expense Ratio
    1.280%
  • Expense Ratio 1.280%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 250,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 49%

USD | NAV as of Jun 17, 2026 | 1-Day Return as of Jun 17, 2026, 12:11 AM GMT+0

Morningstar’s Analysis RFIMX

Will RFIMX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Ranger Micro Cap Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RFIMX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 33.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Phibro Animal Health Corp Class A

4.53 524,355
Healthcare

Ligand Pharmaceuticals Inc

4.50 520,852
Healthcare

PDF Solutions Inc

4.19 485,276
Technology

Solaris Energy Infrastructure Inc Class A

3.06 354,432
Energy

NVE Corp

3.04 352,271
Technology

Karat Packaging Inc

2.88 333,148
Consumer Cyclical

iRadimed Corp

2.83 327,919
Healthcare

Metropolitan Bank Holding Corp

2.83 327,778
Financial Services

Argan Inc

2.73 316,231
Industrials

Pennant Group Inc

2.73 316,175
Healthcare

Sponsor Center